View abstract

Cet abstract a été assigné à session AOB Poster session2
Titre Strontium Brachytherapy in Conjunctival melanoma
Abstract Nr.2035
ButConjunctival melanoma is known for its behaviour as a chronic disease with multiple recurrences in many cases. Excision with adjuvant brachytherapy, and in cases with substantial melanomasis adjuvant local chemotherapy is the treatment of choice on this moment. The purpose of this study is to evaluate the treatment with Strontium brachytherapy in conjunctival melanoma patients.
MéthodesRetrospective study.
Résultats Retrospectively 18 patients (10 males, 8 females) with conjunctival melanoma were identified in the last 20 years. Mean age at first diagnosis was 56.1 years. In 10 patients a dosis of 36 Gy and in 7 patients 50 Gy was used. In 3 patients a recurrence was formed in the treated area (17%) within the mean follow-up time of 4.4 years. None of the patients had scleral problems, cataracts or retinal neovascularisations.
Within the total follow-up time 4 patients died, of which 3 from their melanoma.
Conclusion Strontium brachytherapy after local excision is an effective local treatment for conjunctival melanoma. A therapy of 50 Gray in 5 sessions is nowadays used.
Auteur 1
NomVANDE WALLE
InitialesS
InstitutDept Ophtalmology, Catholic University Leuven
VilleLeuven
Auteur 2
NomSpileers
InitialesW
InstitutDept Ophtalmology, Catholic University Leuven
VilleLeuven
Auteur 3
NomVan Limbergen
InitialesE
InstitutDept Radiotherapy, Catholic University Leuven
VilleLeuven
Auteur 4
NomMissotten
InitialesG
InstitutDept Ophtalmology, Catholic University Leuven
VilleLeuven
top ^